Author:
Rolland Benjamin,Karila Laurent,Franchitto Nicolas,Barrault Camille,Naassila Mickael
Reference11 articles.
1. Agence nationale de sécurité des médicaments et des produits de santé (ANSM). L’ANSM octroie une autorisation de mise sur le marché pour une utilisation du baclofène dans l’alcoolo-dépendance – communiqué. Published on Oct. 23, 2018; updated on Jan. 15, 2021. Available online: https://ansm.sante.fr/actualites/lansm-octroie-une-autorisation-de-mise-sur-le-marche-pour-une-utilisation-du-baclofene-dans-lalcoolo-dependance-communique [consulted on Oct. 10, 2023].
2. Le dernier verre;Ameisen,2008
3. Baclofen for the treatment of alcohol use disorder: the Cagliari Statement;Agabio;Lancet Psychiatry,2018
4. Baclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation;Rolland;Eur Neuropsychopharmacol,2015
5. Risk of hospitalisation and death related to baclofen for alcohol use disorders: comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165,334 patients between 2009 and 2015 in France;Chaignot;Pharmacoepidemiol Drug Saf,2018